Abstract:Breast cancer continues to pose a significant healthcare challenge worldwide for its inherent molecular heterogeneity. This review offers an in-depth assessment of the molecular profiling undertaken to understand this heterogeneity, focusing on multi-omics strategies applied both in traditional bulk and single-cell levels. Genomic investigations have profoundly informed our comprehension of breast cancer, enabling its categorization into six intrinsic molecular subtypes. Beyond genomics, transcriptomics has rendered deeper insights into the gene expression landscape of breast cancer cells. It has also facilitated the formulation of more precise predictive and prognostic models, thereby enriching the field of personalized medicine in breast cancer. The comparison between traditional and single-cell transcriptomics has identified unique gene expression patterns and facilitated the understanding of cell-to-cell variability. Proteomics provides further insights into breast cancer subtypes by illuminating intricate protein expression patterns and their post-translational modifications. The adoption of single-cell proteomics has been instrumental in this regard, revealing the complex dynamics of protein regulation and interaction. Despite these advancements, this review underscores the need for a holistic integration of multiple 'omics' strategies to fully decipher breast cancer heterogeneity. Such integration not only ensures a comprehensive understanding of breast cancer's molecular complexities, but also promotes the development of personalized treatment strategies.

Correction: Breast Cancer Heterogeneity and Its Implication in Personalized Precision Therapy

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses

Tumor Heterogeneity: The Challenge of Precision Medicine

Progress in the Clinical Detection of Heterogeneity in Breast Cancer.

Heterogeneity within molecular subtypes of breast cancer

Molecular heterogeneity in breast cancer: State of the science and implications for patient care

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

Bladder Tumor Heterogeneity: The Impact on Clinical Treatment

Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy

Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications

Clinical management of breast cancer heterogeneity

Advancing Breast Cancer Heterogeneity Analysis: Insights from Genomics, Transcriptomics and Proteomics at Bulk and Single-Cell Levels

Characterization of cancer genomic heterogeneity by next-generation sequencing advances precision medicine in cancer treatment

Lung Cancer Heterogeneity and New Strategies for Drug Therapy.

New Insights from the Widening Homogeneity Perspective to Target Intratumor Heterogeneity

Precision medicine and bladder cancer heterogeneity

Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]

Intratumoral Heterogeneity of Hepatocellular Carcinoma: from Single-Cell to Population-Based Studies

Heterogeneity of the tumor immune microenvironment and its clinical relevance